Israel - English - Ministry of Health

unipharm ltd, israel - sertraline as hydrochloride - coated tablets - sertraline as hydrochloride 50 mg - sertraline - for the treatment of symptoms of depression in patients with or without a history of mania. following satisfactory respose, continuation with sertaline therapy is effective in preventon relapse of the initial episode of depression or recurrence of further depressive episodes.

United States - English - NLM (National Library of Medicine)

spring hill therapeutics llc - pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ginger (unii: c5529g5jpq) (ginger - unii:c5529g5jpq) - pyridoxine hydrochloride 75 mg - b-serene rx is indicated to provide b-vitamin supplementation, with ginger to help calm preganancy related nausea and vomiting (morning sickness), and may be used in conjunction with a physician prescribed prenatal regimen. on wounds or damaged skin. children under 12 years old, consult a doctor. if you are allergic to any ingredients in this product. if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor. keep out of the reach of children.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - haloperidol -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - haloperidol -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - haloperidol -

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - haloperidol, quantity: 1.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; calcium hydrogen phosphate; acacia; magnesium stearate - antipsychotic

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - haloperidol, quantity: 5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; calcium hydrogen phosphate; acacia; brilliant scarlet 4r; magnesium stearate - antipsychotic

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - haloperidol, quantity: 0.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; calcium hydrogen phosphate; acacia; magnesium stearate; quinoline yellow; green s - antipsychotic

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - haloperidol, quantity: 20 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; calcium hydrogen phosphate; acacia; magnesium stearate; indigo carmine aluminium lake - acute & chronic schzophrenia, mania &hypomania, organic psychoses agitation in psychotic illness, explosive hyperexcitability & extreme hyperactivity in children, motorics & vocal utterances of gile de la tourette's sydndrome, anxiety neurosis & tension states, mixed neurosis where features of depression acompany anxiety.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - haloperidol, quantity: 0.5 mg - tablet - excipient ingredients: maize starch; lactose monohydrate; calcium hydrogen phosphate dihydrate; acacia; magnesium stearate; tartrazine - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, senile psychosis, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therpay: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy